Kekule Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 19.00 Cr
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 108.45 Cr
- Satisfied Charges ₹ 109.15 Cr
- Revenue Growth -99.68%
- Profit Growth -97.31%
- Ebitda -98.87%
- Net Worth -98.40%
- Total Assets -99.06%
About Kekule Pharma
Kekule Pharma Limited (KPL) is a Public Limited Indian Non-Government Company incorporated in India on 29 November 1984 and has a history of 40 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 19.00 Cr.
The company currently has active open charges totaling ₹108.45 Cr. The company has closed loans amounting to ₹109.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kekule Pharma Limited India are Srilakshmi Kudaravalli as CFO and Harimohan Namdev as Company Secretary. Nadella Rao, Kudaravalli Rao, Kudaravalli Durgarani, and Three other members serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231TG1984PLC005145
-
Company No.
005145
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
29 Nov 1984
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Kekule Pharma Limited offer?
Kekule Pharma Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Kekule Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harimohan Namdev
|
Company Secretary | 21-Aug-2020 | Current |
|
Kudaravalli Sridhar
|
Managing Director | 20-Feb-1998 | Current |
|
Srilakshmi Kudaravalli
|
CFO | 01-Apr-2016 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Nadella Rao
|
Director | 03-Mar-2017 | Current |
|
Kudaravalli Rao
|
Whole-Time Director | 26-May-2004 | Current |
|
Kudaravalli Durgarani
|
Whole-Time Director | 15-Jun-2001 | Current |
|
Srilakshmi Kudaravalli
|
Whole-Time Director and Cfo | 20-Feb-1998 | Current |
|
Jaswanthi Chittabathini
|
Director | 13-Feb-2024 | Current |
Financial Performance of Kekule Pharma.
Kekule Pharma Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.68% decrease. The company also saw a substantial fall in profitability, with a 97.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kekule Pharma?
Unlock access to Kekule Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Techno Industries Private LimitedHarimohan Namdev is a mutual person
-
Kekule Pharmaceuticals (A.P) LimitedKudaravalli Rao, Kudaravalli Durgarani and 1 more are mutual person
-
Kekule Life Sciences LimitedKudaravalli Rao, Kudaravalli Sridhar and 1 more are mutual person
-
Madhava Hi-Tech Cold Storage Private LimitedNadella Rao is a mutual person
-
Premier Klenz Private Limited
Kudaravalli Rao and Kudaravalli Durgarani are mutual person
-
Alpha Energy Systems Limited
Kudaravalli Rao is a mutual person
Charges (Loans)
₹108.45 Cr
₹109.15 Cr
Charges Breakdown by Lending Institutions
- Others : 108.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2023 | Others | ₹39.50 Cr | Open |
| 28 Apr 2022 | Others | ₹58.95 Cr | Open |
| 30 Jul 2020 | Others | ₹10.00 Cr | Open |
| 28 Mar 2022 | Others | ₹2.60 Cr | Satisfied |
| 09 Sep 2020 | Others | ₹2.77 Cr | Satisfied |
How Many Employees Work at Kekule Pharma?
Kekule Pharma has a workforce of 166 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kekule Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kekule Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
